|
Delayed
Hong Kong S.E.
08:48:07 11/09/2026 +03
|
5-day change | 1st Jan Change | ||
| 1.630 HKD | +1.88% |
|
-6.59% | -64.10% |
| 09-03 | Cutia Therapeutics' Marketing Application for Botox Product Accepted in China | MT |
| 09-03 | Cutia Therapeutics Announces Biologics License Application for Cu-20101 Accepted by Nmpa | CI |
Company Valuation: Cutia Therapeutics
Data adjusted to current consolidation scope
| Fiscal Period: December | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|
| Market Cap 1 | 3,030 | 2,120 | 1,482 | 497.6 | - | - |
| Change | - | -30.05% | -30.06% | -66.43% | - | - |
| Enterprise Value (EV) 1 | 2,471 | 2,055 | 1,469 | 566.3 | 497.6 | 335.9 |
| Change | - | -16.83% | -28.53% | -61.44% | -12.13% | -32.49% |
| P/E | -1.04x | -4.72x | -3.96x | -2.99x | 10.5x | 1.32x |
| PBR | 2.25x | 2.17x | 1.52x | 1.08x | 0.98x | 0.71x |
| PEG | -0x | 0.1x | 0.1x | 0.1x | -0x | 0x |
| Capitalization / Revenue | 22x | 7.58x | 4.41x | 0.77x | 0.42x | 0.29x |
| EV / Revenue | 18x | 7.35x | 4.37x | 0.88x | 0.42x | 0.19x |
| EV / EBITDA | -4.96x | -4.89x | -5.69x | -4.77x | 6.1x | 0.76x |
| EV / EBIT | -4.58x | -4.46x | -4.89x | -3.95x | 9.43x | 1.38x |
| EV / FCF | -5.65x | -4.38x | -4.87x | -1.85x | -17.6x | 5.45x |
| FCF Yield | -17.7% | -22.8% | -20.5% | -54.2% | -5.68% | 18.4% |
| Dividend per Share 2 | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - |
| EPS 2 | -9.6 | -1.41 | -1.03 | -0.4581 | 0.1304 | 1.038 |
| Distribution rate | - | - | - | - | - | - |
| Net sales 1 | 137.6 | 279.6 | 336.2 | 645.9 | 1,180 | 1,738 |
| EBITDA 1 | -498 | -419.9 | -257.9 | -118.8 | 81.56 | 444.6 |
| EBIT 1 | -538.9 | -461.1 | -300.1 | -143.3 | 52.79 | 244.1 |
| Net income 1 | -1,964 | -433.8 | -340.2 | -145.7 | 44.25 | 330.6 |
| Net Debt 1 | -559.6 | -64.73 | -13.8 | 68.7 | - | -161.7 |
| Reference price 2 | 9.967 | 6.653 | 4.080 | 1.369 | 1.369 | 1.369 |
| Nbr of stocks (in thousands) | 304,024 | 318,588 | 363,368 | 363,368 | - | - |
| Announcement Date | 3/27/24 A | 3/24/25 A | 3/24/26 A | - | - | - |
1CNY in Million2CNY
Estimates
P/E, Detailed evolution
| P/E (N) | EV / Sales (N) | EV / EBITDA (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.99x | 0.88x | -4.77x | - | 74.15M | |
| 31.96x | 11.62x | 23.56x | 0.62% | 1,001B | |
| 29.63x | - | - | 2.02% | 642B | |
| 32.65x | 7.56x | 15.72x | 2.69% | 451B | |
| 18.78x | 4.58x | 11.35x | 2.9% | 340B | |
| 19.52x | 5.11x | 12.66x | 3.19% | 263B | |
| 20.44x | 4.2x | 12.01x | 2.1% | 247B | |
| 24.19x | 6.38x | 11.35x | 2.64% | 207B | |
| 12.74x | 4.63x | 9.67x | 3.94% | 197B | |
| -43.8x | 6.4x | 24.98x | 2.27% | 180B | |
| Average | 14.31x | 5.70x | 12.95x | 2.48% | 352.64B | |
| Weighted average by Cap. | 23.23x | 7.75x | 17.18x | 2.04% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- 2487 Stock
- Valuation Cutia Therapeutics
Select your edition
All financial news and data tailored to specific country editions
